2012
DOI: 10.1016/j.colsurfb.2011.11.016
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
34
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 77 publications
(35 citation statements)
references
References 31 publications
1
34
0
Order By: Relevance
“…On the other hand, it has been reported that the capability of drugs to penetrate across the cornea can be significantly improved by decreasing the particle size using nanoparticles [3,9,[13][14][15]. Ophthalmic formulations containing drug nanoparticles present a possible solution to the limitations surrounding ocular drug penetration [16][17][18][19], and it is known that decreasing direct cellular stimulation and reducing the amount drug used by increasing its bioavailability are useful ways to circumvent the side effects related to drug delivery [6]. It is expected that ophthalmic drug systems using nanoparticles may provide an alternative strategy for increasing ocular drug penetration [16][17][18][19].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…On the other hand, it has been reported that the capability of drugs to penetrate across the cornea can be significantly improved by decreasing the particle size using nanoparticles [3,9,[13][14][15]. Ophthalmic formulations containing drug nanoparticles present a possible solution to the limitations surrounding ocular drug penetration [16][17][18][19], and it is known that decreasing direct cellular stimulation and reducing the amount drug used by increasing its bioavailability are useful ways to circumvent the side effects related to drug delivery [6]. It is expected that ophthalmic drug systems using nanoparticles may provide an alternative strategy for increasing ocular drug penetration [16][17][18][19].…”
Section: Introductionmentioning
confidence: 99%
“…Ophthalmic formulations containing drug nanoparticles present a possible solution to the limitations surrounding ocular drug penetration [16][17][18][19], and it is known that decreasing direct cellular stimulation and reducing the amount drug used by increasing its bioavailability are useful ways to circumvent the side effects related to drug delivery [6]. It is expected that ophthalmic drug systems using nanoparticles may provide an alternative strategy for increasing ocular drug penetration [16][17][18][19]. This review addresses the usefulness of ophthalmic formulations containing drug nanoparticles.…”
Section: Introductionmentioning
confidence: 99%
“…10 Therefore, strategies of combining polymer nanoparticles with active enhancement techniques for improving transdermal drug permeation have been investigated. [11][12][13] Active strategies for enhancing drug permeation include iontophoresis, electroporation, ultrasound, and microneedle pretreatment. [14][15][16][17] To some extent, these enhancement approaches can promote percutaneous drug penetration.…”
Section: Introductionmentioning
confidence: 99%
“…It is expected that drug systems using nanoparticles may provide an alternative strategy for increasing drug bioavailability. [19][20][21][22] On the other hand, we have also developed methods to prepare tranilast solid nanoparticles by a bead mill method, and showed that these solid nanoparticles enhance drug bioavailability. 23,24) It is possible that decreasing the amount of orally administered NSAIDs by improving their bioavailability may lead to an expansion of their usage as therapy for RA patients.…”
mentioning
confidence: 99%
“…[16][17][18] Implants fabricated using the biodegradable polymer PLGA [poly(DL-lactide-co-glycolide)] with mean particle diameters of 50-200 nm have been widely utilized as carriers for bioactive molecules and present a possible solution to limitations surrounding ocular drug penetration. [19][20][21][22] In addition, Sha et al 18) developed a newly designed oral nanotherapeutic using redox nanoparticles (RNP O ) with the potential to scavenge reactive oxygen species including nitroxide radicals for the treatment of inflammation in the gastrointestinal tract. RNP O is a core-shell-type polymeric micelle prepared by the self-assembly of methoxy-poly(ethylene glycol)-b-poly[4-(2,2,6,6-tetramethylpiperidine-1-oxyl) oxymethyl-styrene].…”
mentioning
confidence: 99%